Publicaciones en colaboración con investigadores/as de Hospital del Mar (64)

2024

  1. Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

    Biomedicine and Pharmacotherapy, Vol. 176

  2. Coping behaviors to reduce anxiety and depressive symptoms: A prospective repeated assessment study

    Spanish Journal of Psychiatry and Mental Health

  3. Hallmarks of pancreatic cancer: spotlight on TAM receptors

    eBioMedicine, Vol. 107

  4. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

    Nutrition Journal, Vol. 23, Núm. 1

  5. Validation of ZIP4 as a tumour-associated antigen for nanotargeting

    Journal of Drug Targeting

2023

  1. Electrochemical immunoplatform to help managing pancreatic cancer

    Journal of Electroanalytical Chemistry, Vol. 935

  2. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

    Cells, Vol. 12, Núm. 6

  3. Improved estimation of the risk of manic relapse by combining clinical and brain scan data

    Revista de Psiquiatria y Salud Mental

  4. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

    Nature communications, Vol. 14, Núm. 1, pp. 746

  5. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  6. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)

    Scientific Reports

  2. Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice

    Blood, Vol. 139, Núm. 2, pp. 228-239

  3. Electrochemical immunosensing of Growth arrest-specific 6 in human plasma and tumor cell secretomes

    Electrochemical Science Advances, Vol. 2, Núm. 4

  4. Endocannabinoid signaling of homeostatic status modulates functional connectivity in reward and salience networks

    Psychopharmacology, Vol. 239, Núm. 5, pp. 1311-1319

  5. Exploring the Role of Galectins in Cancer : In Vitro and In Vivo Approaches

    Methods in Molecular Biology (Humana Press Inc.), pp. 685-711

  6. Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

    Journal of Clinical Medicine, Vol. 11, Núm. 12

  7. Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells

    Cancers, Vol. 14, Núm. 4

  8. Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice

    Cancers, Vol. 14, Núm. 24

  9. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

    eBioMedicine, Vol. 75